Progyny, Inc. (PGNY) Stock
PGNY Key Statistics
About Progyny, Inc.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
CEO: Pete Anevski. Company website
PGNY — Frequently Asked Questions
What is the PGNY stock price today?
Progyny, Inc. (PGNY) trades at $27.13, up 0.44% on the day, as of Sep 20, 2026 14:57 UTC.
What is Progyny, Inc.'s market cap?
Progyny, Inc. has a market capitalisation of $2.13B, calculated from the live PGNY share price and shares outstanding.
What is the P/E ratio of PGNY?
PGNY trades at a trailing P/E of 29.49, from earnings per share of $0.92 over the last twelve months.
How much revenue does Progyny, Inc. make?
Progyny, Inc. generated revenue of $1.31B over the trailing twelve months, which puts the stock at 1.62 times sales.
What is the 52-week range for PGNY?
PGNY has traded between $16.10 and $33.07 over the past 52 weeks, and the last price is 18.0% below that high.
Is Progyny, Inc. profitable?
Yes. Progyny, Inc. keeps 6.00% of revenue as net income over the trailing twelve months.
What is the analyst price target for PGNY?
Wall Street analysts rate PGNY Buy, with an average price target of $35.50, 30.9% above the current price.
What sector is Progyny, Inc. in?
Progyny, Inc. is classified under the Healthcare sector and the Medical - Healthcare Plans industry, and is domiciled in US.
Who is the CEO of Progyny, Inc.?
Pete Anevski is the chief executive of Progyny, Inc., which employs 846 people.
Where can I track PGNY in real time?
QFI Terminal shows PGNY with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See PGNY live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open PGNY in Terminal See plans